▲ Peaking
Business
FDA Approves Centanafadine for ADHD in Children, Adolescents, and Adults
The FDA has approved Otsuka's Simtriyo (centanafadine), the first new-class ADHD medication for pediatric and adult patients in decades.
Treatment of Attention-Deficit Hyperactivity Disorder ADHD
1 news trends Newsylist has tracked involving Treatment of Attention-Deficit Hyperactivity Disorder ADHD — newest first.